They don't have to, if NCE was given it would just appear in the OB.
And if it was to be granted they would have done it right away.
But they can't give EPA-ethyl ESTER NCE status so it just won't appear.
AMRN mgt knows this and that is why Joe Z have been trying to downplay the NCE.
And docs and patients couldn't give a damn if 96% EPA-E has NCE status, hence it means nothing.
No large pharma will buy AMRN anyway, so it really means nothing.
hard to believe that after 7 months, FDA has not given some indication as to the reason for delaying NCE decision. The quickly building patent portfolio should make NCE meaningless, but we know this stock would jump big if it were granted.